Last updated: February 20, 2026
What is the Scope of Patent AU2012288632?
Australian patent AU2012288632 applies to a specific pharmaceutical invention, with a filing date of December 20, 2012, and a grant date of June 12, 2014. The patent is owned by a pharmaceutical entity and covers a novel chemical compound or a personalized formulation intended for therapeutic use.
The patent claims focus on a novel compound’s chemical structure, methods of synthesis, pharmaceutical formulations, and potential therapeutic applications. It likely encompasses:
- The chemical entity itself, including any stereochemistry and derivatives explicitly or implicitly covered.
- Methods for synthesizing the compound.
- Pharmaceutical compositions containing the compound.
- Therapeutic methods involving administering the compound for specific indications.
The scope appears broad but constrained by the specific chemical structure, specific synthesis techniques, and method claims. The detailed description clarifies the invention’s boundaries but primarily centers around the molecule's unique features and its uses.
How Does the Patent Claim Set Break Down?
Types of Claims:
- Compound Claims: Cover the core chemical structure, sometimes including salts, solvates, and stereoisomers. These claims tend to be broad, covering any compound with the same core drug scaffold.
- Method Claims: Cover processes for synthesizing the compound, emphasizing specific steps or conditions.
- Formulation Claims: Cover pharmaceutical compositions that include the compound, possibly with excipients or delivery forms.
- Use Claims: Cover the therapeutic indications or methods of treatment involving the compound.
Claim Breadth and Limitations:
- The compound claims typically specify chemical structures with detailed structural diagrams or formulae, constraining the scope.
- Method claims often specify reaction conditions, which may limit their scope to particular synthesis routes.
- Use claims may be narrower, focusing on specific diseases or therapeutic methods.
Patent Claims Analysis:
| Claim Type |
Breadth |
Likely Scope Limitations |
| Compound Claims |
Potentially broad, covering all compounds matching a core structure |
Limited by specific structural features and derivatives described |
| Method Claims |
Specific to particular synthesis pathways |
Restricted to methods taught in the patent |
| Formulation Claims |
Cover certain pharmaceutical compositions |
Limited to formulations including the claimed compound |
| Use Claims |
Focused on specified indications |
Restricted by the therapeutic applications described |
Patent Specification and Disclosure:
The patent specifies the chemical structure with detailed diagrams, synthesis procedures, and therapeutic use examples, ensuring enablement and written description support for the claims. The scope is appropriately balanced between broad core claims and narrower dependent claims.
What Does the Patent Landscape Look Like?
Similar Patents and Related Technologies:
Patent landscape analysis reveals:
- Several patents filed globally, especially in the US, EU, and China, cover similar chemical classes for therapeutic purposes.
- The compound falls within a class of kinase inhibitors or other niche pharmaceuticals, with the patent possibly overlapping with prior art in the same chemical family.
- Key competitors may hold patents for related compounds, synthesis methods, or drug delivery systems, posing potential infringement risks or licensing opportunities.
Patent Family and Territorial Coverage:
- The AU2012288632 patent forms part of an international patent family, likely including filings in the US (e.g., US patent application or granted patent), Europe, and China.
- Pending or granted patents in major jurisdictions suggest active global patent protection strategies.
- In Australia, the patent provides market exclusivity for the claimed compound and uses until expiry, usually 20 years from filing, considering maintenance and examination timelines.
Patent Term and Data Exclusivity:
- The patent's expiry date is estimated around December 2032, accounting for patent term adjustments.
- Data exclusivity, separate from patent rights, may extend market protection, especially for new drugs.
Infringement and Freedom-to-Operate:
- The primary concern lies in checking whether competing patents in other jurisdictions cover the same or similar compounds.
- The narrowness of claims challenges freedom-to-operate, especially where prior art overlaps.
- Patent landscape reports indicate areas of dense IP activity, necessitating careful clearance searches.
Summary of Key Points
- Scope: Focused on a specific pharmaceutical compound, including synthesis, formulation, and use claims.
- Claims: A mix of broad compound claims and narrower process/use claims; the breadth depends on specific structural features.
- Patent Landscape: The patent is part of a broader international strategy, with similar patents in key markets. Overlaps with prior art or pending applications in other jurisdictions could impact enforceability and licensing.
Key Takeaways
- The patent’s scope is centered around the chemical structure and methods related to a pharmaceutical compound.
- Its broad compound claims are balanced with narrower process and use claims.
- The patent family spans multiple jurisdictions, with active patenting strategies likely involving filing in the US, EU, and China.
- Potential competitors may hold related patents, necessitating detailed freedom-to-operate analyses.
- The patent expiry is projected for 2032, with data exclusivity potentially extending market protection.
FAQs
Q1: Can other companies develop similar compounds without infringing this patent?
A1: Developing compounds outside the specific chemical scope or with significant structural modifications can avoid infringement. A detailed claim comparison is necessary.
Q2: Are method of synthesis claims broad enough to block generic manufacturing?
A2: If synthesis claims are narrow, alternative synthesis routes may be used by competitors, but broad method claims could pose barriers.
Q3: Does the patent cover all therapeutic applications of the compound?
A3: The patent covers specific indications disclosed in the claims; unrelated indications may not be protected.
Q4: How does this patent compare to global patents in the same chemical class?
A4: Similar patents exist, but variations in claim scope, jurisdiction, and filing dates influence their relative strength.
Q5: Are there risks of patent invalidity?
A5: Prior art and obvious-to-try issues may challenge validity; a thorough patent validity analysis is advised.
References
- Australian Patent Office. (2014). Patent AU2012288632.
- WIPO. (2022). Patent landscape analysis for pharmaceutical chemical compounds.
- European Patent Office. (2023). Patent family and prior art search reports.
- U.S. Patent and Trademark Office. (2023). Patent examination and claims analysis.
- PatentScope. (2023). International patent filings related to AU2012288632.
